Business · 29/05/2001Updated: 10/17/2026 · 1 min read
FDA Revokes Biologics Licenses for Bacterial Vaccines and Related Products
The US Food and Drug Administration (FDA) has revoked certain biologics licenses at the request of the license holders, following a proposed rule for the implementation of efficacy reviews for bacterial vaccines and related products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →